2017 49c & 11c Semipostal,Alzheimer's Research

# B6 - 2017 49c & 11c Semipostal - Alzheimer's Research

$2.00 - $53.00
Image Condition Price Qty
821159
Fleetwood First Day Cover Ships in 1-3 business days. Ships in 1-3 business days.
$ 3.75
$ 3.75
0
821161
Fleetwood First Day Cover (Plate Block) Ships in 1-3 business days. Ships in 1-3 business days.
$ 8.50
$ 8.50
1
833436
Mint Plate Block Ships in 1-3 business days. Ships in 1-3 business days.
$ 13.25
$ 13.25
2
833431
Mint Stamp(s) Ships in 1-3 business days. Ships in 1-3 business days. Free with 790 Points
$ 2.75
$ 2.75
3
No Image
Mint Sheet(s) Ships in 1-3 business days. Ships in 1-3 business days.
$ 53.00
$ 53.00
4
833433
Used Single Stamp(s) Ships in 1-3 business days. Ships in 1-3 business days.
$ 2.00
$ 2.00
5
Show More - Click Here
Mounts - Click Here
Mount Price Qty

United States Issues New Semipostal Stamp

In 2017, the USPS announced a new 10-year Semipostal stamp program with the first in the series being the 2017 Alzheimer's stamp.  The stamp has the same design as the 2008 Alzheimer's Awareness stamp, but with the woman facing right on the new Semipostal, instead of left.  President Ronald Reagan declared November National Alzheimer's Disease Awareness Month in 1983, so it's only fitting the 2017 stamp's First Day of Issue was in November.  Proceeds from the sale of the Alzheimer's Semipostal went to the US Department of Health and Human Services to fund Alzheimer's disease research.

Read More - Click Here

United States Issues New Semipostal Stamp

In 2017, the USPS announced a new 10-year Semipostal stamp program with the first in the series being the 2017 Alzheimer's stamp.  The stamp has the same design as the 2008 Alzheimer's Awareness stamp, but with the woman facing right on the new Semipostal, instead of left.  President Ronald Reagan declared November National Alzheimer's Disease Awareness Month in 1983, so it's only fitting the 2017 stamp's First Day of Issue was in November.  Proceeds from the sale of the Alzheimer's Semipostal went to the US Department of Health and Human Services to fund Alzheimer's disease research.